U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
TEMELIMAB
T32CR1A69R
Investigational
General
Names
5
Classification
1
Identifiers
5
Subunits
4
Related Substances
1
TEMELIMAB
T32CR1A69R
Investigational
General
Approval Year
Unknown
139,594
Names
5
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
TEMELIMAB
Official Name
English
IMMUNOGLOBULIN G4, ANTI-(MULTIPLE SCLEROSIS-ASSOCIATED RETROVIRUS VIRAL ENVELOPE PROTEIN) (HUMAN-MUS MUSCULUS MONOCLONAL GNBAC1 HEAVY CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL GNBAC1 .KAPPA.-CHAIN, DIMER
Common Name
English
Temelimab [WHO-DD]
Common Name
English
GNBAC1
Code
English
temelimab [INN]
Common Name
English
Showing 1 to 5 of 5 entries
Previous
1
Next
Classification
1
Show
5
20
100
All
entries
Classification Tree
Code System
Code
Classification Tree
Code System
Code
Designated
ORPHAN DRUG
Designated
Treatment of chronic inflammatory demyelinating polyradiculoneuropathy/polyneuropathy (CIDP)
FDA ORPHAN DRUG
625517
Showing 1 to 1 of 1 entries
Previous
1
Next
Identifiers
5
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
CAS
1393641-34-3
PRIMARY
FDA UNII
T32CR1A69R
PRIMARY
NCI_THESAURUS
C170386
PRIMARY
DRUG BANK
DB15634
PRIMARY
INN
10830
PRIMARY
Showing 1 to 5 of 5 entries
Previous
1
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
T32CR1A69R
TEMELIMAB